London pre-open: Doubts about further Chinese stimulus
20th Aug 2012 07:43
City sources predict the FTSE 100 will open up five points from Friday's close of 5,852, having gained 18 points during Friday's session following positive data from the US. Over the weekend it was reported in Europe by the Handelsblatt newspaper that the European Union could appoint the European
Read moreProteome Sciences reports collaboration research agreement
20th Aug 2012 07:20
Biotech group Proteome Sciences has agreed to work with CHDI Foundation Inc on a systems biology project regarding Huntington's disease. Initially, Proteome will provide its PS Biomarker Services protein profiling to CHDI's research programmes. The analyses will be performed at Proteome's facility
Read moreProteome issues new licence for stroke product
5th Apr 2012 11:50
Pharma group Proteome Sciences has granted a non-exclusive licence to UK firm Randox Laboratories for its portfolio of stroke biomarkers. Under the terms of the agreement Randox will develop products for early diagnosis of stroke and subsequent monitoring of treatment outcomes. Proteome will ear
Read moreProteome rockets on Alzheimer's blood test
28th Mar 2012 10:46
Pharma group Proteome Sciences has had a strong morning on the markets after announcing success in its project to develop better diagnostic tools for Alzheimer's disease. A study of 1,000 patients has shown three distinct "biomarkers" in people's blood which can discriminate between mild "cognitive
Read moreStroke consortium to get €11m grant
19th Mar 2012 10:17
Shares in biomarker specialist Proteome Sciences rose almost 5% on Monday morning after it announced the EU was to award €11m to a consortium of which it is a member. Euro-HYP-1, a consortium of academic, clinical and industrial European partners that includes Proteome, has been awarded the grant f
Read moreProteome boosted by Sanofi settlement
27th May 2011 12:09
Biomarker specialist Proteome Sciences is back in profit after receiving €11m from Sanofi-Aventis to settle a warranty claim. The company posted pre-tax profits of £4.59m in the year to the end of December, including the warranty claim. This compared £4.20m pre-tax loss in 2009. Revenues for 2010
Read moreSmall caps round-up: Tinci, Nasstar, 600 Group...
30th Nov 2010 13:34
Environmental engineering group Tinci Holdings jumped after it announced contracts worth 45.4m Chinese Renminbi (£4.34m) to provide paper desulfurisation technology to two subsidiaries of the Dongguan Jiulong Paper Group. These projects are expected to start shortly and last for about six months. N
Read moreUK SMALLCAP ROUNDUP: African Minerals Gets $1.5B For Tonkolili
13th Jul 2010 09:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps AFRICAN MINERALS LTD. (AMI.LN), an iron ore miner focused on Sierra Leone, Tuesday said it agreed a $1.5 billion investment in its Tonkolili project from
Read moreProteome Sciences Develops Two Alzheimer's Tests
13th Jul 2010 08:03
LONDON (Dow Jones)--Diagnostics company Proteome Sciences PLC (PRM.LN) Tuesday said it developed two tests focused on aspects of Alzheimer's disease. The company, which specializes in identifying proteins that could be hallmarks of disease, said one of the tests measures levels of nine proteins
Read moreProteome Sciences: German Court To Hear Sanofi Case End July
18th Jun 2010 07:25
LONDON (Dow Jones)--Proteome Sciences PLC (PRM.LN), a life sciences company delivering content for personalised medicine, said Friday it has received notification from the Civil Division of the Higher Regional Court in Frankfurt that the Court now intends to take witness evidence at the end of July
Read moreProteome seals Alzheimer's tie-up
6th Jul 2009 07:17
Proteome Sciences has signed an exclusive license agreement with Millipore Corp to develop new products aimed at helping advance the study of Alzheimer's disease. The disease identification specialist says Millipore will develop Luminex bead-based multiplex immunoassays to measure Proteome Sciences
Read moreProteome extends loan facility
18th Jun 2009 08:08
Revenue rose strongly at disease identification specialist Proteome Sciences last year but cash inflows have fallen short of expectations. Revenue in 2008 rose to £0.85m from £0.27m in 2007 while loss before tax narrowed to £4.8m from £5.5m the year before. Cash in hand at the end of 2008 stood at
Read more